Remove Clinical Trials Remove DEA Remove Recreational
article thumbnail

MDMA Failed to Receive FDA Approval: What Happens Next?

Veriheal

MDMA, also known as ‘molly’ or ‘ecstasy’ in the recreational drug scene, is a synthetic compound that produces euphoric, prosocial, empathetic, stimulant, and psychedelic effects. Methodological Concerns with Blinding A particular concern raised by the FDA is the lack of effective blinding in the clinical trials.

article thumbnail

Justice Department Urged To Take “Immediate Action” On Marijuana Grow Applications

NORML

” Last year, however, former DEA director Robert Patterson testified to Congress that the agency believed that approving additional applicants would likely violate international anti-drug treaties. Patterson said that DEA could not move forward granting any new applications until the Justice Department clarified the issue. .

DEA
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Scientists Sue DEA as it Drags its Feet and Hampers Cannabis Research

WeedAdvisor

Despite mounting evidence into cannabis’ therapeutic benefits, the DEA continues to close its eyes and plug its ears, constantly claiming that there is not enough research to support its medicinal value, according to Marijuana Moment. It could be argued that the DEA is hesitant for the sake of public safety. A Vicious Circle. .

DEA
article thumbnail

Cannabis and International Trade: Never the Twain Shall Meet?

Canna Law Blog

Canada legalized recreational marijuana for the entire country. took significant steps to decriminalize or legalize medical or recreational marijuana. Drug Enforcement Administration (DEA) granted permission for a Canadian marijuana company (Tilray) to export medicinal cannabis to University of California San Diego for clinical trial.

article thumbnail

Psychedelic Revolution Version 2.0: Save Lives & Dismantle War on Fungus

NewsMunchies

In clinical trials, psilocybin (the psychoactive substance in mushrooms) has shown tremendous promise in treating severe depression, post-traumatic stress disorder, and other mental illnesses. Additional clinical trials underway in the U.S. We know such categorization is baseless and false.

article thumbnail

U.S. Funding Focuses on Marijuana’s Harms, Not Benefits

CannaMD

In Canada, recreational marijuana use was legalized in October 2018. The end result is a powdery low-potency substance that is not representative of what people are actually consuming today in the 30+ states that have legalized cannabis for medical and/or recreational use. The DEA would then be the exclusive distributor.

DEA
article thumbnail

New U.S. Research Efforts Could Catalyze Medical Cannabis’ Adoption in the Pharmaceutical Industry

Veriheal

Cannabis, despite being widely available for medical and recreational consumers across the United States, remains one of the most understudied plants. Drug Enforcement Agency (DEA). Additionally, numerous other cannabis-based medications have already gained approval or are in the process of being tested in clinical trials.